Priya Sachdeva

Stock Analyst at UBS

(0.88)

# 3,609

Out of 4,820 analysts

4

Total ratings

25%

Success rate

-6.31%

Average return

Main Sectors:

Top Industries:

Medical Devices

Stocks Rated by Priya Sachdeva

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	PEN Penumbra	Maintains: Buy	$320 → $330	$300.25	+9.91%	3	Apr 24, 2025
	NPCE NeuroPace	Initiates: Buy	$17	$11.15	+52.53%	1	Jan 21, 2025

Penumbra

Apr 24, 2025

Maintains: Buy

Price Target: $320 → $330

Current: $300.25

Upside: +9.91%

NeuroPace

Jan 21, 2025

Initiates: Buy

Price Target: $17

Current: $11.15

Upside: +52.53%